Dimensional Fund Advisors LP Landec Corp \Ca\ Transaction History

Dimensional Fund Advisors LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	N/A	-1,718,647 Reduced 97.79%	38,897 $0
Q4 2022 Feb 09, 2023	SELL	$0.0 - $9.95 $0 - $759,762	-76,358 Reduced 4.16%	1,757,544 $0
Q3 2022 Nov 10, 2022	SELL	$8.57 - $11.57 $837,340 - $1.13 Million	-97,706 Reduced 5.06%	1,833,902 $16.3 Million
Q2 2022 Aug 12, 2022	SELL	$8.84 - $11.64 $348,950 - $459,477	-39,474 Reduced 2.0%	1,931,608 $19.3 Million
Q1 2022 May 13, 2022	SELL	$10.07 - $11.93 $25,436 - $30,135	-2,526 Reduced 0.13%	1,971,082 $22.8 Million
Q4 2021 Feb 09, 2022	SELL	$7.95 - $11.24 $470,337 - $664,980	-59,162 Reduced 2.91%	1,973,608 $21.9 Million
Q3 2021 Nov 12, 2021	SELL	$9.22 - $12.44 $343,196 - $463,054	-37,223 Reduced 1.8%	2,032,770 $18.7 Million
Q2 2021 Aug 12, 2021	SELL	$9.91 - $12.78 $658,886 - $849,703	-66,487 Reduced 3.11%	2,069,993 $23.3 Million
Q1 2021 May 14, 2021	SELL	$10.44 - $12.22 $865,277 - $1.01 Million	-82,881 Reduced 3.73%	2,136,480 $22.7 Million
Q4 2020 Feb 25, 2021	BUY	$9.3 - $11.77 $20.6 Million - $26.1 Million	2,219,361 New	2,219,361 $24.1 Million

20.4M

65.8K

14.1K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.